SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Round Rock, TX.

TSS Inc

TSSI is actively discussed following a significant price drop driven by a recent earnings report that highlighted operational delays at its new data center facility. However, community members are divided, with many viewing the decline as an overreaction, citing TSSI's integral role as a Dell partner in the booming AI infrastructure and edge computing sector, while others remain concerned about management transparency and future revenue streams. Bulls point to management's assurances of resolved issues and strong projected growth for the coming year, particularly in high-margin rack integration for next-gen AI systems.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is experiencing a significant surge in community interest, driven by anticipation of an upcoming announcement and strong bullish sentiment for substantial upside potential. While many users express belief in a rapid price increase, a vocal segment of the community also raises concerns about potential 'rug pull' schemes and its legitimacy, reflecting the highly speculative nature of the asset. Concurrently, new investors are actively discussing how to acquire the token, highlighting its emerging but unestablished market presence.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MULN is trending as its related crypto token, 'MullenArmy' on the Solana network, sees active promotion and debate. The community is highly polarized, with proponents highlighting its potential for growth and referencing a Forbes article, while a significant number of investors dismiss it as another 'scam' coin, heavily influenced by the original stock's history of severe dilution and reverse splits.

Ambiq Micro, Inc. engages in the provision of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI computing. It operates through the following geographical segments: China, Taiwan, Singapore, and Rest of the World. The company was founded by Scott Hanson, Dennis Sylvester, and David Blaauw on January 20, 2010 and is headquartered in Austin, TX.

Ambiq Micro Inc.

Ambiq Micro, Inc.

Ambiq Micro is trending as the community speculates on imminent major partnerships, notably an anticipated Oura Ring deal and further collaborations for its ultra-low-power edge AI chips, which were a focus at CES. Investors are highly optimistic about the company's disruptive technology and significant market cap potential within the rapidly expanding wearables and AI sectors. Conversation also centers on future product details and strategic announcements that could unlock substantial value.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is generating significant buzz following its recent integration with World Liberty Finance for USD1 payroll and card services, alongside high anticipation for its upcoming Super App launch. The community is overwhelmingly bullish, emphasizing ZBCN's real-world utility in on-chain payments, robust compliance, and favorable tokenomics. Investors view it as an early opportunity with substantial growth potential, often drawing comparisons to established crypto projects due to its expanding partnerships and future blockchain integrations.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin ($XCN) is trending following its recent listing on Robinhood and strategic expansion into the South Korean market, driving significant community discussion. Enthusiastic investors anticipate major developments like the upcoming "Goliath Mainnet" will fuel substantial growth, while others express skepticism, citing concerns over past price manipulation and the project's anonymous developer team. This polarization creates a dynamic debate around its potential for sustained upside versus a repeat of previous volatility cycles.

Corsair Gaming, Inc. designs and supplies hardware components for personal computers. It operates through the Gamer and Creator Peripherals, and Gaming Components and Systems segments. The Gamer and Creator Peripherals segment offers gaming keyboards, mice, headsets, controllers, and gaming gear including capture cards, Stream Decks, USB microphones, studio accessories, and EpocCam software, as well as coaching and training services. The Gaming Components and Systems segment focuses on creating power supply units, or PSUs, cooling solutions, computer cases, DRAM modules, prebuilt, and custom-built gaming PCs. The company was founded by Andrew J. Paul in 1994 and is headquartered in Milpitas, CA.

Corsair Gaming Inc

Corsair Gaming is trending following strong Q4 results, with community conversation heavily focused on how surging memory prices are significantly boosting the company's profitability. Investors are optimistic about an ongoing PC hardware upgrade cycle, fueled by new GPUs and anticipated game releases, which is expected to drive demand across Corsair's diverse product portfolio and higher-margin peripherals. Many perceive the stock as currently undervalued, anticipating continued positive momentum.

Amtech Systems, Inc. engages in the manufacture of semiconductors and capital equipment. It operates through the Semiconductor and Material and Substrate segments. The Semiconductor segment involves the designing, manufacturing, selling, and servicing of thermal processing equipment and related controls for use by semiconductor manufacturers, and in electronics, automotive, and other industries. The Material and Substrate segment produces consumables and machinery for lapping and polishing materials, such as sapphire substrates, optical components, silicon wafers, and numerous types of crystal materials, ceramics, and metal components. The company was founded by Jong S. Whang in October 1981 and is headquartered in Tempe, AZ.

Amtech Systems Inc.

Amtech Systems is trending after reporting stronger-than-expected earnings, driven by robust demand for advanced packaging, particularly in AI infrastructure. The community is actively discussing the company's potential as a key beneficiary of the semiconductor sector's momentum and record global chip sales, often comparing its specialized offerings to other industry players.

SoftBank Group Corp. operates as a holding company which engages in the management of its group companies. It operates through the following segments: SoftBank Vision Fund, SoftBank, Arm, Brightstar, and Others. The SoftBank Vision Fund segment engages in the investment business. The SoftBank segment provides mobile communication, broadband, and telecom services in Japan. The Arm segment designs microprocessors and develops software technologies. The Brightstar segment engages in the distribution of mobile devices overseas. The Others segment includes the smartphone payments business, alternative investment business, fund business in Latin America and the operation of baseball teams. The company was founded by Masayoshi Son on September 3, 1981 and is headquartered in Tokyo, Japan.

SoftBank Group Corp. - ADR

SoftBank Corp.

SoftBank is actively trending due to its aggressive pivot into artificial intelligence, spearheaded by founder Masayoshi Son, with recent moves including significant funding efforts for a new AI chip venture, substantial investments in OpenAI-linked data centers, and the strategic acquisition of AI chip designers. Community discussion centers on whether these bold capital reallocations, such as divesting from Nvidia and T-Mobile, signal a confident long-term bet on shaping the AI ecosystem or if they echo past investment risks, especially as the company positions Arm Holdings at the core of its AI ambitions.

Atlas Critical Minerals Corp. is a mineral exploration company, which focuses on minerals projects and properties in Brazil. The firm also operates an iron ore mine Its portfolio includes mineral properties for rare earths, graphite, uranium, titanium, copper, nickel, iron ore, gold, and quartzite. The company was founded by Marc Fogassa on July 27, 2016 and is headquartered in Belo Horizonte, Brazil.

Atlas Critical Minerals Corp.

Atlas Critical Minerals Corp. (ATCX) is trending following its recent Nasdaq uplisting from OTC, alongside the confirmation of nuclear-grade graphite and the commencement of iron ore revenue generation. The community is actively discussing the company's clean capital structure, low float, and diversified portfolio of Brazilian critical minerals, including rare earths, which are gaining attention due to the recently signed EU-Mercosur trade deal. Investors are evaluating ATCX as potentially undervalued compared to peers, anticipating significant growth in the critical minerals sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amalgamated Bank Raises Stock Position in AbbVie Inc. $ABBV

Amalgamated Bank boosted its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 1.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange...

Dividend Stocks To Add to Your Watchlist - January 17th

Exxon Mobil, AbbVie, and Chevron are the three Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that regularly distribute a...

Pharmaceutical Stocks To Follow Today - January 17th

AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, AbbVie, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are...

AbbVie Inc. $ABBV Shares Sold by WoodTrust Financial Corp

WoodTrust Financial Corp cut its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 74.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The...

QRG Capital Management Inc. Sells 75,094 Shares of AbbVie Inc. $ABBV

QRG Capital Management Inc. lowered its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 25.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned...

AbbVie Call Options Spike 2,599%: Tracking the Big Bet

Large institutional investors are positioning for growth as a leading biopharmaceutical firm enters the obesity market and reaches a federal agreement...

AbbVie (NYSE:ABBV) Stock Price Down 1.1% - Time to Sell?

AbbVie (NYSE:ABBV) Trading Down 1.1% - Should You Sell...

<ul class="summary-bullets"><li>While the study also showed an improvement in other key aspects such as complete response rates and duration of response, it did not demonstrate a statistically significant improvement in overall survival.&nbsp;</li><li>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common and aggressive type of non-Hodgkin lymphoma.</li><li>The company said it now intends to engage with regulatory authorities to discuss the next steps for the drug together with its partner AbbVie.</li></ul> Genmab A/S (GMAB) said on Friday that its late-stage trial evaluating drug Epcoritamab demonstrated an improvement in progression-free survival in certain patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma.While the study also showed an improvement in other key aspects such as complete response rates and duration of response, it did not demonstrate a statistically significant improvement in overall survival, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/01/16/3220513/0/en/Genmab-Announces-Topline-Results-for-Epcoritamab-DuoBody-CD3xCD20-from-Phase-3-EPCORE-DLBCL-1-Trial-in-Patients-with-Relapsed-Refractory-Diffuse-Large-B-cell-Lymphoma-DLBCL.html">said.</a> While progression-free survival represents the time a patient lives with cancer without it getting worse or dying, overall survival is the length of time from diagnosis or treatment start until death from any cause.<h2 class="st-heading-2">Study Details</h2>Genmab enrolled 483 patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma in the trial who had undergone at least one prior line of therapy. These patients were ineligible for high-dose chemotherapy, the company said.Diffuse Large B-Cell Lymphoma (DLBCL) is the most common and aggressive type of non-Hodgkin lymphoma, a blood cancer involving rapid growth of large B-lymphocytes in the lymphatic system, lymph nodes, and other organs, often presenting as fast-growing masses or swollen nodes with symptoms like fever, night sweats, and weight loss. According to Genmab, there are approximately 25,000 new cases of DLBCL diagnosed each year in the U.S.The company said it intends to now engage with regulatory authorities to discuss the next steps for the drug together with its partner AbbVie. Epcoritamab, being co-developed by Genmab and AbbVie, is already approved in several countries for the treatment of certain lymphomas.Shares of GMAB fell 5% at the time of writing.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around GMAB stock stayed within the ‘bearish’ territory coupled with ‘high’ message volume.Meanwhile, sentiment around ABBV shares rose from ‘bearish’ to ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘extremely high’ levels.A Stocktwits user sees GMAB stock plummet down to $20 from current levels.<stembedurl>https://www.stocktwits.com/nopumpdump/message/642093162</stembedurl><a href="https://stocktwits.com/symbol/GMAB">GMAB stock</a> has gained 51% over the past 12 months while <a href="https://stocktwits.com/symbol/ABBV">ABBV shares</a> added 24%.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/nvo-shares-rise-on-strong-kickstart-for-wegoy-pill-in-us/cmUlCCgR4Bq">NVO Shares Rise On Strong Kickstart For Wegovy Pill In US: Retail Eyes Up To $110 As ‘Fair Value’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Genmab logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Genmab Stock Drops On Mixed Results From Late-Stage Trial Of Lymphoma Drug

Epcoritamab demonstrated an improvement in progression-free survival in certain patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma, the company said.

Equity

Epcoritamab demonstrated an improvement in progression-free survival in certain patients with relapsed or refractory diffuse large B-cell lymphoma, the company said.


AbbVie Announces Topline Results for Epcoritamab (DuoBody CD3xCD20) from Phase 3 EPCORE DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

AbbVie Announces Topline Results for Epcoritamab (DuoBody CD3xCD20) from Phase 3 EPCORE DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) AbbVie Announces...

Pharmaceutical Stocks To Keep An Eye On - January 16th

Eli Lilly and Company, Novo Nordisk A/S, AbbVie, Pfizer, Abbott Laboratories, AstraZeneca, and BridgeBio Pharma are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock...

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

ABBV
Abbvie Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABBV News

ABBVAbbvie Inc